UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells

PloS one, 2010-04, Vol.5 (4), p.e9982-e9982

2010

Volltextzugriff (PDF)

E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells

Molecular biology of the cell, 2007-08, Vol.18 (8), p.2838-2851

2007

Volltextzugriff (PDF)

O 6-Methylguanine-DNA methyltransferase inactivation and chemotherapy

British medical bulletin, 2008-03, Vol.85 (1), p.17-33

2008

Volltextzugriff (PDF)

Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro

The journal of gene medicine, 2009-02, Vol.11 (2), p.169-179

2009

Volltextzugriff (PDF)

Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)

Cancer Immunology, Immunotherapy, 2009-10, Vol.58 (10), p.1657-1667

2009

Volltextzugriff (PDF)

A cancer cell-specific inducer of apoptosis

Human gene therapy, 2007-06, Vol.18 (6), p.547-561

2007

Volltextzugriff (PDF)

The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29

2006

Volltextzugriff (PDF)

Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11)

The journal of gene medicine, 2007-04, Vol.9 (4), p.244-252

2007

Volltextzugriff (PDF)

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase

The journal of gene medicine, 2006-05, Vol.8 (5), p.557-565

2006

Volltextzugriff (PDF)

O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy

British medical bulletin, 2008-03, Vol.85 (1), p.17-33

2008

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972-979

2006

Volltextzugriff (PDF)

669. Drug Selection of Hematopoietic Cells by Regulated MGMT Activity

Molecular therapy, 2006-05, Vol.13 (S1), p.S258-S258

2006

Volltextzugriff (PDF)

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29-34

2006

Volltextzugriff (PDF)

Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium

Metabolic brain disease, 1999-12, Vol.14 (4), p.205-221

1999

Volltextzugriff (PDF)

1044. Radioprotective Gene Therapy through Retroviral Expression of Manganese Superoxide Dismutase

Molecular therapy, 2005-05, Vol.11 (S1), p.S404-S404

2005

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P [sub]140K mutant of O [sup]6-methylguanine-DNA-methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972

2006

Volltextzugriff (PDF)

Dual agent chemoprotection by retroviral co‐expression of either MDR1 or MRP1 with the P 140 K mutant of O 6 ‐methylguanine‐DNA‐methyl transferase

The journal of gene medicine, 2006-08, Vol.8 (8), p.972-979

2006

Volltextzugriff (PDF)

The P140K mutant of human O [sup]6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O [sup]6-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29

2006

Volltextzugriff (PDF)

The P140K mutant of humanO6-methylguanine-DNA-methyltransferase (MGMT) confers resistancein vitro andin vivo to temozolomide in combination with the novel MGMT inactivatorO6-(4-bromothenyl)guanine

The journal of gene medicine, 2006-01, Vol.8 (1), p.29-34

2006

Volltextzugriff (PDF)

Gene transfer into neural cells in vitro using adenoviral vectors

Current Protocols in Neuroscience, 2001-05, Vol.Chapter 4 (1), p.Unit 4.23

2001

Volltextzugriff (PDF)

Chapter 33 Gene therapy for inherited neurological disorders: Towards therapeutic intervention in the Lesch-Nyhan syndrome

Progress in Brain Research, 1998, Vol.117, p.485-501

1998

Volltextzugriff (PDF)

A Proofreading Mutation with an Allosteric Effect Allows a Cluster of SARS-CoV-2 Viruses to Rapidly Evolve

Molecular biology and evolution, 2023-10, Vol.40 (10)

2023

Volltextzugriff (PDF)

Assessing the technical skills of surgical trainees

British journal of surgery, 2005-06, Vol.92 (6), p.778-782

2005

Volltextzugriff (PDF)

sFDvent: A global trait database for deep‐sea hydrothermal‐vent fauna

Global ecology and biogeography, 2019-11, Vol.28 (11), p.1538-1551

2019

Volltextzugriff (PDF)

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Cell, 2021-01, Vol.184 (1), p.64-75.e11

2021

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells

E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells

O 6-Methylguanine-DNA methyltransferase inactivation and chemotherapy

Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro

Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)

A cancer cell-specific inducer of apoptosis

The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine

Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11)

Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase

O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase

669. Drug Selection of Hematopoietic Cells by Regulated MGMT Activity

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium

1044. Radioprotective Gene Therapy through Retroviral Expression of Manganese Superoxide Dismutase

Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P [sub]140K mutant of O [sup]6-methylguanine-DNA-methyl transferase

Dual agent chemoprotection by retroviral co‐expression of either MDR1 or MRP1 with the P 140 K mutant of O 6 ‐methylguanine‐DNA‐methyl transferase

The P140K mutant of human O [sup]6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O [sup]6-(4-bromothenyl)guanine

The P140K mutant of humanO6-methylguanine-DNA-methyltransferase (MGMT) confers resistancein vitro andin vivo to temozolomide in combination with the novel MGMT inactivatorO6-(4-bromothenyl)guanine

Gene transfer into neural cells in vitro using adenoviral vectors

Chapter 33 Gene therapy for inherited neurological disorders: Towards therapeutic intervention in the Lesch-Nyhan syndrome

A Proofreading Mutation with an Allosteric Effect Allows a Cluster of SARS-CoV-2 Viruses to Rapidly Evolve

Assessing the technical skills of surgical trainees

sFDvent: A global trait database for deep‐sea hydrothermal‐vent fauna

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Suchergebnisse filtern